Profil
Dewey Steadman is currently the Head of Investor Relations at United Therapeutics Corp.
Previously, he worked as the Executive Director of Investor and Media Relations at Akorn, Inc.
Postes actifs de Dewey Steadman
| Sociétés | Poste | Début |
|---|---|---|
| UNITED THERAPEUTICS CORPORATION | Investor Relations Contact | - |
Anciens postes connus de Dewey Steadman
| Sociétés | Poste | Fin |
|---|---|---|
| AKORN, INC. | Investor Relations Contact | - |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| UNITED THERAPEUTICS CORPORATION | Health Technology |
| Entreprise privées | 1 |
|---|---|
Akorn, Inc.
 Akorn, Inc. Pharmaceuticals: MajorHealth Technology Akorn, Inc. engages in the development, manufacture, and marketing of generic and prescription pharmaceuticals, and animal and consumer health products. It manufactures and markets branded and generic products including ophthalmic, injectable, oral liquids, topical, inhalants, and nasal sprays. The company was founded in 1971 and is headquartered in Lake Forest, IL. | Health Technology |
